Meet us at these upcoming events
Whether you are looking to talk to us about our science, partnering or investment opportunities, you can meet the Confo Therapeutics team who will be participating at the following conferences:
The 34th Protein Structure Determination in Industry (PSDI 2026) meeting brings together industrial structural biologists to discuss advances and techniques in integrated structural biology.
BIO-Europe is the major global biopharma partnering and strategy event where biotech, pharma, investors, and other life-science leaders meet to forge partnerships, explore licensing and investment opportunities, and discuss the strategic forces shaping the industry.
The preeminent international conference for obesity researchers and clinicians, ObesityWeek is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy.
The 19th European Bioanalysis Forum (EBF) Open Symposium, themed “Fearless Science – Driven by Curiosity, Guided by Data,” brings together the global bioanalytical community to exchange knowledge and discuss advances in bioanalysis, analytical technologies and regulatory developments relevant to drug development.
This conference is the largest healthcare-dedicated investor conference in Europe.
The 18th PEGS Europe Summit (Protein & Antibody Engineering Summit Europe) is one of Europe’s largest conferences focused on biologics, protein engineering, and antibody therapeutics. It brings together scientists, biotech companies, and pharmaceutical researchers to discuss advances in drug discovery and development, particularly for cancer, autoimmune diseases, and other complex conditions.
Confo will be present as invited speaker.
This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
The 11th RSC-BMCS Symposium on Mastering Medicinal Chemistry (Mastering MedChem XI) brings together medicinal chemists from industry and academia to discuss the latest strategies, methods and challenges in drug discovery and the development of next-generation therapeutics
This partnering conference connects Europe’s top innovation centers with the global life sciences industry to cultivate thriving, strategic partnerships.
The event brings together endocrine specialists from across Europe and the rest of the world to meet and collaborate on endocrinology. There will be delegates from over 100 countries who will explore the latest in endocrine research and development.
Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs.
The Signature Annual Meeting in Endocrinology with over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions. ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.
This partnering conference is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
The EASD 2027 meeting will bring together thousands of clinicians, scientists and healthcare professionals in Budapest to discuss the latest advances across basic, translational and clinical diabetes research, including new therapeutic approaches, obesity and metabolic disease, diabetes technology, and cardiovascular and renal complications.
BioCentury Grand Rounds – Europe is a life sciences/biopharma conference focused on turning early-stage academic research into investable biotech and new medicines. It brings together academic researchers, biotech leaders, pharma R&D/business-development executives and investors to discuss emerging disease biology, new therapeutic approaches, AI/enabling technologies, and the challenges of translating discoveries from the lab into the clinic.
Organized by the Cambridge Healthtech Institute, this premier conference showcases breakthroughs driving the future of therapeutic drug discovery. The scientific program spans seven concurrent tracks covering advances in target discovery, lead generation, and next-generation biologics. The event connects over 1,100 global participants and 250 speakers through expert lectures, training seminars, and poster sessions.